Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Health

>> PANCREATIC CANCER Latest News

SEP 19, 2014 - MedPage Today

A Must Read - Share

New Regimens Boost Optimism for Pancreatic Ca (CME/CE)

SAN FRANCISCO (MedPage Today) -- Stereotactic ablative radiation allowed 40% of patients with inoperable pancreatic cancer to proceed to surgery, which left no residual disease in 92% of cases, interim results from a small clinical study showed.

Tags: New Regimens Boost Optimism for Pancreatic Ca (CME/CE),  Pancreatic Cancer Latest News

SEP 19, 2014 - Futurity

A Must Read - Share

Berry extract added to chemo kills pancreatic cancer

A chemotherapy drug was more effective at killing pancreatic cancer cells when an extract from chokeberries was added to the … Continued The post Berry extract added to chemo kills pancreatic cancer appeared first on Futurity.

Tags: Berry extract added to chemo kills pancreatic cancer,  Pancreatic Cancer Latest News

SEP 18, 2014 - Health Canal

A Must Read - Share

Wild berry extract may strengthen effectiveness of pancreatic cancer drug

A wild berry native to North America may strengthen the effectiveness of a chemotherapy drug commonly used to treat pancreatic cancer, reveals research published online in the Journal of Clinical Pathology.

Tags: Wild berry extract may strengthen effectiveness of pancreatic cancer drug,  Pancreatic Cancer Latest News

SEP 18, 2014 - Philadelphia Inquirer

A Must Read - Share

Jeanne R. Koller, 79, teacher

Jeanne R. Koller, 79, of Roxborough, the first African American teacher at Ardmore Avenue Elementary School in Lower Merion, who went on to a long teaching career in Philadelphia, died Sunday, Sept. 14, of pancreatic cancer at her home.

Tags: Jeanne R. Koller, 79, teacher,  Pancreatic Cancer Latest News

SEP 17, 2014 - Yahoo! News

A Must Read - Share

Gilead's experimental drug fails mid-stage study

(Reuters) - Gilead Sciences Inc said its experimental drug did not significantly improve how long patients with a type of pancreatic cancer lived without the disease worsening. The mid-stage study evaluated the drug, simtuzumab, in combination with chemotherapy, against a placebo plus chemotherapy, in previously untreated patients with advanced pancreatic cancer. The study failed its main goal of improving progression-free-survival ...

Tags: Gilead's experimental drug fails mid-stage study,  Pancreatic Cancer Latest News